ORAL MELPHALAN THERAPY IN ADVANCED MALIGNANT DISEASE.
D000293:Adolescent; D002648:Child; D005853:Geriatrics; D006258:Head and Neck Neoplasms; D006689:Hodgkin Disease; D006801:Humans; D007938:Leukemia; D007945:Leukemia, Lymphoid; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008339:Mandibular Neoplasms; D008441:Maxillary Neoplasms; D008545:Melanoma; D008558:Melphalan; D009101:Multiple Myeloma; D009369:Neoplasms / Q000628:therapy*; D009918:Orbital Neoplasms; D010954:Plasmacytoma; D012509:Sarcoma; D012514:Sarcoma, Kaposi
D008558:Melphalan
ADOLESCENCE; CHILD; GERIATRICS; HODGKIN'S DISEASE; LEUKEMIA, LYMPHOCYTIC; LYMPHOSARCOMA; MANDIBULAR NEOPLASMS; MAXILLARY NEOPLASMS; MELANOMA; MELPHALAN; MULTIPLE MYELOMA; NECK NEOPLASMS; NEOPLASM THERAPY; ORBITAL NEOPLASMS; PLASMACYTOMA; SARCOMA, KAPOSI'S; SARCOMA, RETICULUM CELL